Pain News and Research

Latest Pain News and Research

Medical websites provide harmful information about postherpetic neuralgia treatments

Health information is plentiful on the Internet and many Web surfers consider medical advice they find online to be a cheaper alternative to visiting a doctor, according to some studies. However, the risk of obtaining useless or even harmful medical information from some websites is high for patients with postherpetic neuralgia, a common complication of shingles, according to new research reported in The Journal of Pain, published by the American Pain Society.

1 Dec 2011

Neuropharmacology to publish Nutra Pharma's Alpha-Cobratoxin mechanism study on chronic pain

Nutra Pharma Corporation, a biotechnology company that is developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain, announced today that the journal Neuropharmacology will be publishing a mechanism study on the use of Alpha-Cobratoxin, a component of cobra venom, as a treatment for pain.

1 Dec 2011

Ranbaxy and Teva announce generic Lipitor agreement

Teva Pharmaceutical Industries Ltd. announced today that pursuant to an agreement between its subsidiary, Teva Pharmaceuticals USA, Inc. and Ranbaxy Laboratories Limited, a portion of the profits from Ranbaxy's sales of Atorvastatin Calcium Tablets during Ranbaxy's 180-day first-to-file exclusivity period, will be paid to Teva.

1 Dec 2011

One-time injection after spinal cord injury can limit pain for 8 months

A collaborative research group - led by researchers at Cleveland Clinic - published findings that indicate a one-time injection immediately after spinal cord injury can limit pain for an extended period of time.

30 Nov 2011

Coronary CTA reveals different heart attack risk scenarios for men and women

Findings on coronary CT angiography (CTA), a noninvasive test to assess the coronary arteries for blockages, show different risk scenarios for men and women, according to a study presented today at the Radiological Society of North America.

30 Nov 2011

Ranbaxy receives FDA approval for first generic version of cholesterol-lowering drug Lipitor

The U.S. Food and Drug Administration today approved the first generic version of the cholesterol-lowering drug Lipitor.

30 Nov 2011

Dramatic nationwide rise in opioid use for chronic abdominal pain

Across U.S. outpatient clinics between 1997 and 2008, opioid prescriptions for chronic abdominal pain more than doubled, according to a new study in Clinical Gastroenterology and Hepatology, the official journal of the American Gastroenterological Association.

30 Nov 2011

Genentech announces results from pertuzumab studies on HER2-positive breast cancer

Genentech, a member of the Roche Group, today announced the company will present results from studies of its investigational medicine pertuzumab in HER2-positive breast cancer at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium December 6-10.

30 Nov 2011

Mayo Clinic becomes FUS Foundation's new Research Award recipient

The Focused Ultrasound Surgery Foundation has announced that its Research Awards Program is funding a Mayo Clinic study that will be the first to use U.S. commercial database information to compare the costs of three minimally-invasive treatments for symptomatic uterine fibroids, a benign and often debilitating condition that affects more than one in four American women.

30 Nov 2011

Anemia, high blood pressure linked to risk of silent strokes in children with SCD

A team of researchers from the Johns Hopkins Children's Center, Vanderbilt University and elsewhere have demonstrated that high blood pressure and anemia together put children with sickle cell disease (SCD) at serious danger for symptomless or so-called "silent" strokes, although either condition alone also signaled high risk.

30 Nov 2011

Mandatory cuts: Winners and losers in the post-super committee landscape

Many domestic programs will feel pain, but Medicaid appears to be part of the "protected" class. Meanwhile, news outlets continue to report on the pending Medicare physician pay cut and how fixing this scheduled reduction could trigger cuts in other parts of the health care sector.

30 Nov 2011

EC extends therapeutic indication for Soliris to treat atypical hemolytic uremic syndrome

Alexion Pharmaceuticals, Inc. today announced that the European Commission (EC) has extended the therapeutic indication for Soliris® (eculizumab) to include the treatment of pediatric and adult patients with atypical hemolytic uremic syndrome (aHUS).

29 Nov 2011

BioLineRx reports third quarter net loss of NIS 7.9 million

BioLineRx Ltd., a biopharmaceutical development company, today reported its results for the third quarter ending September 30, 2011.

29 Nov 2011

First Edition: November 29, 2011

Reporting for Kaiser Health News, and working in collaboration with The Washington Post, Sandra G. Boodman writes: "Propelled by the Post-9/11 GI Bill, which took effect in 2009, 2 million veterans, many of whom served in Iraq and Afghanistan, are eligible for generous benefits that can amount to a full scholarship.

29 Nov 2011

IVC filter study reinforces SIR's guidelines surrounding retrieval or permanent placement

Researchers have published the largest single patient population study to date on a method for following patients with retrievable inferior vena cava (IVC) filters-devices used to keep blood clots from traveling to the lungs.

29 Nov 2011

Combination of other opioids with methadone therapy can lead to overdose or fatal consequences

A new study has shown harmful prescription patterns of powerful painkillers among a substantial number of Ontario patients who received methadone therapy to treat their opioid addiction.

29 Nov 2011

The Doctors features Ellman's Pelleve Wrinkle Reduction System

The Pelleve Wrinkle Reduction System was featured in a live demonstration on The Doctors on November 17th. Top dermatologist Dr. Ava Shamban of Santa Monica, CA performed the treatment, giving the audience and viewers a first-hand look at how Pelleve works.

28 Nov 2011

Bacterin to distribute Jeil's LeForte craniomaxillofacial system in the U.S. and Canada

Bacterin International Holdings, Inc., a leader in the development of revolutionary bone graft material and antimicrobial coatings for medical applications, signed an exclusive agreement with Jeil Medical Corporation for distribution in the U.S. and Canada of Jeil's LeForte System.

28 Nov 2011

Inspiration commences enrollment in second OBI-1 Accur8 clinical trial program for congenital hemophilia A

Inspiration Biopharmaceuticals, Inc. today announced the initiation of patient enrollment in the second of two pivotal studies in the Company's OBI-1 Accur8 clinical trial program.

28 Nov 2011

Bayer, Regeneron commence EYLEA Phase 3 clinical trial for wet AMD in China

Regeneron Pharmaceuticals, Inc. and Bayer HealthCare today announced that they have initiated a Phase 3 clinical trial evaluating the efficacy and safety of EYLEA (aflibercept) Injection in the neovascular form of age-related macular degeneration (wet AMD) in China.

28 Nov 2011

Pain News and Research

Latest Pain News and Research

Medical websites provide harmful information about postherpetic neuralgia treatments

Neuropharmacology to publish Nutra Pharma's Alpha-Cobratoxin mechanism study on chronic pain

Ranbaxy and Teva announce generic Lipitor agreement

One-time injection after spinal cord injury can limit pain for 8 months

Coronary CTA reveals different heart attack risk scenarios for men and women

Ranbaxy receives FDA approval for first generic version of cholesterol-lowering drug Lipitor

Dramatic nationwide rise in opioid use for chronic abdominal pain

Genentech announces results from pertuzumab studies on HER2-positive breast cancer

Mayo Clinic becomes FUS Foundation's new Research Award recipient

Anemia, high blood pressure linked to risk of silent strokes in children with SCD

Mandatory cuts: Winners and losers in the post-super committee landscape

EC extends therapeutic indication for Soliris to treat atypical hemolytic uremic syndrome

BioLineRx reports third quarter net loss of NIS 7.9 million

First Edition: November 29, 2011

IVC filter study reinforces SIR's guidelines surrounding retrieval or permanent placement

Combination of other opioids with methadone therapy can lead to overdose or fatal consequences

The Doctors features Ellman's Pelleve Wrinkle Reduction System

Bacterin to distribute Jeil's LeForte craniomaxillofacial system in the U.S. and Canada

Inspiration commences enrollment in second OBI-1 Accur8 clinical trial program for congenital hemophilia A

Bayer, Regeneron commence EYLEA Phase 3 clinical trial for wet AMD in China

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Pain News and Research

Latest Pain News and Research

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Newsletters you may be interested in